Strong Trigger
now
Reaches operational break-even (BEP) for the first time following surging institutional adoption and hospital formulary listings for Type 1 diabetes delay drug 'Tzield'.
24h Trigger History
No history available
No trigger updates found for this ticker in the last 24 hours.
| Advertisement |